Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail

Published
13 Mar 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
R$11.90
14.3% undervalued intrinsic discount
08 Aug
R$10.20
Loading
1Y
-7.4%
7D
1.8%

Author's Valuation

R$11.9

14.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 0.76%

Shared on24 Apr 25
Fair value Decreased 4.06%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 2.75%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.67%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on02 Apr 25
Fair value Decreased 7.97%

Shared on26 Mar 25
Fair value Increased 4.36%

AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to -0.0%.

Shared on19 Mar 25
Fair value Increased 4.12%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to 0.0%.